| Target Price | $5.10 |
| Price | $4.25 |
| Potential |
20.00%
register free of charge
|
| Number of Estimates | 7 |
|
7 Analysts have issued a price target Adverum Biotechnologies Inc 2026 .
The average Adverum Biotechnologies Inc target price is $5.10.
This is
20.00%
register free of charge
$31.50
641.18%
register free of charge
$4.04
4.94%
register free of charge
|
|
| A rating was issued by 12 analysts: 9 Analysts recommend Adverum Biotechnologies Inc to buy, 3 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Adverum Biotechnologies Inc stock has an average upside potential 2026 of
20.00%
register free of charge
|
| Analyst | Rating | Action | Date |
|---|---|---|---|
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Nov 17 2025 |
| RBC Capital |
Locked
➜
Locked
|
Locked | Oct 28 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Sep 23 2025 |
| Chardan Capital |
Locked
➜
Locked
|
Locked | Aug 13 2025 |
| Mizuho |
Locked
➜
Locked
|
Locked | Jun 26 2025 |
| Chardan Capital |
Locked
➜
Locked
|
Locked | May 15 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | May 15 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Nov 17 2025 |
|
Locked
RBC Capital:
Locked
➜
Locked
|
Oct 28 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Sep 23 2025 |
|
Locked
Chardan Capital:
Locked
➜
Locked
|
Aug 13 2025 |
|
Locked
Mizuho:
Locked
➜
Locked
|
Jun 26 2025 |
|
Locked
Chardan Capital:
Locked
➜
Locked
|
May 15 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
May 15 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


